152 related articles for article (PubMed ID: 26432401)
21. Clinical appraisal of 99m technetium-sestamibi SPECT/CT compared to conventional SPECT in patients with primary hyperparathyroidism and concomitant nodular goiter.
Pata G; Casella C; Besuzio S; Mittempergher F; Salerni B
Thyroid; 2010 Oct; 20(10):1121-7. PubMed ID: 20615139
[TBL] [Abstract][Full Text] [Related]
22. Preoperative 4D CT Localization of Nonlocalizing Parathyroid Adenomas by Ultrasound and SPECT-CT.
Hinson AM; Lee DR; Hobbs BA; Fitzgerald RT; Bodenner DL; Stack BC
Otolaryngol Head Neck Surg; 2015 Nov; 153(5):775-8. PubMed ID: 26248963
[TBL] [Abstract][Full Text] [Related]
23. SPECT/CT-Guided Ultrasound for Parathyroid Adenoma Localization: A 1-Stop Approach.
Touska P; Elstob A; Rao N; Parthipun A
J Nucl Med Technol; 2019 Mar; 47(1):64-69. PubMed ID: 30139883
[TBL] [Abstract][Full Text] [Related]
24. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy.
Lavely WC; Goetze S; Friedman KP; Leal JP; Zhang Z; Garret-Mayer E; Dackiw AP; Tufano RP; Zeiger MA; Ziessman HA
J Nucl Med; 2007 Jul; 48(7):1084-9. PubMed ID: 17574983
[TBL] [Abstract][Full Text] [Related]
25. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
[TBL] [Abstract][Full Text] [Related]
26. Comparison of single photon emission CT (SPECT) with SPECT/CT imaging in preoperative localization of parathyroid adenomas: A cost-effectiveness analysis.
Barber B; Moher C; Côté D; Fung E; O'Connell D; Dziegielewski P; Harris J
Head Neck; 2016 Apr; 38 Suppl 1():E2062-5. PubMed ID: 26849426
[TBL] [Abstract][Full Text] [Related]
27. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.
Gayed IW; Kim EE; Broussard WF; Evans D; Lee J; Broemeling LD; Ochoa BB; Moxley DM; Erwin WD; Podoloff DA
J Nucl Med; 2005 Feb; 46(2):248-52. PubMed ID: 15695783
[TBL] [Abstract][Full Text] [Related]
28. Comparison of 4D CT, ultrasonography, and 99mTc sestamibi SPECT/CT in localizing single-gland primary hyperparathyroidism.
Suh YJ; Choi JY; Kim SJ; Chun IK; Yun TJ; Lee KE; Kim JH; Cheon GJ; Youn YK
Otolaryngol Head Neck Surg; 2015 Mar; 152(3):438-43. PubMed ID: 25518904
[TBL] [Abstract][Full Text] [Related]
29. Virtual neck exploration: a new method for localizing abnormal parathyroid glands.
Prommegger R; Wimmer G; Profanter C; Sauper T; Sieb M; Kovacs P; Bale R; Putzer D; Gabriel M; Margreiter R
Ann Surg; 2009 Nov; 250(5):761-5. PubMed ID: 19806053
[TBL] [Abstract][Full Text] [Related]
30. The diagnostic accuracy of neck ultrasound, 4D-Computed tomographyand sestamibi imaging in parathyroid carcinoma.
Christakis I; Vu T; Chuang HH; Fellman B; Figueroa AMS; Williams MD; Busaidy NL; Perrier ND
Eur J Radiol; 2017 Oct; 95():82-88. PubMed ID: 28987702
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Accuracy of
Parihar AS; Mhlanga J; Ronstrom C; Schmidt LR; Figenshau RS; Dehdashti F; Wahl RL
J Nucl Med; 2023 Jan; 64(1):90-95. PubMed ID: 35772963
[TBL] [Abstract][Full Text] [Related]
32. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma.
Lorberboym M; Minski I; Macadziob S; Nikolov G; Schachter P
J Nucl Med; 2003 Jun; 44(6):904-8. PubMed ID: 12791817
[TBL] [Abstract][Full Text] [Related]
33. Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors.
Gorin MA; Rowe SP; Baras AS; Solnes LB; Ball MW; Pierorazio PM; Pavlovich CP; Epstein JI; Javadi MS; Allaf ME
Eur Urol; 2016 Mar; 69(3):413-6. PubMed ID: 26386607
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid Imaging with Simultaneous Acquisition of 99mTc-Sestamibi and 123I: The Relative Merits of Pinhole Collimation and SPECT/CT.
Bhatt PR; Klingensmith WC; Bagrosky BM; Walter JC; McFann KK; McIntyre RC; Raeburn CD; Koo PJ
J Nucl Med Technol; 2015 Dec; 43(4):275-81. PubMed ID: 26584615
[TBL] [Abstract][Full Text] [Related]
35. Sestamibi/iodine subtraction single photon emission computed tomography in reoperative secondary hyperparathyroidism.
Neumann DR; Esselstyn CB; Madera AM
Surgery; 2000 Jul; 128(1):22-8. PubMed ID: 10876181
[TBL] [Abstract][Full Text] [Related]
36. [Usefulness of imaging techniques in secondary hyperparathyroidism].
Torregrosa JV; Félez I; Fuster D
Nefrologia; 2010; 30(2):158-67. PubMed ID: 20098464
[TBL] [Abstract][Full Text] [Related]
37. Technetium-99m-sestamibi subtraction scintigraphy vs. ultrasonography combined with a rapid parathyroid hormone assay in parathyroid aspirates in preoperative localization of parathyroid adenomas and in directing surgical approach.
Barczynski M; Golkowski F; Konturek A; Buziak-Bereza M; Cichon S; Hubalewska-Dydejczyk A; Huszno B; Szybinski Z
Clin Endocrinol (Oxf); 2006 Jul; 65(1):106-13. PubMed ID: 16817828
[TBL] [Abstract][Full Text] [Related]
38. 11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery.
Traub-Weidinger T; Mayerhoefer ME; Koperek O; Mitterhauser M; Duan H; Karanikas G; Niederle B; Hoffmann M
J Clin Endocrinol Metab; 2014 Nov; 99(11):4199-205. PubMed ID: 25029418
[TBL] [Abstract][Full Text] [Related]
39. The key role of 99mTc-MIBI SPECT/CT in the diagnosis of parathyroid adenoma: a case report.
Li Q; Pan J; Luo Q; Wang Y; Bao Y; Jia W
Arch Endocrinol Metab; 2015 Jun; 59(3):265-9. PubMed ID: 26154096
[TBL] [Abstract][Full Text] [Related]
40. Quantitative application of dual-phase 99mTc-sestamibi SPECT/CT imaging of parathyroid lesions: identification of optimal timing in secondary hyperparathyroidism.
Wang Y; Liu Y; Li N; Xu K; Zhang W
EJNMMI Phys; 2023 Apr; 10(1):29. PubMed ID: 37079194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
